Drug-Price Transparency in Communications Act

referredUnited States· United States Congress· EN

Introduced

26 July 2018

Last action

27 July 2018 · Referred

Status

Referred to the Subcommittee on Health.

Summary

Drug-Price Transparency in Communications Act This bill amends the Federal Food, Drug, and Cosmetic Act to impose a civil penalty on any person who disseminates a direct-to-consumer drug advertisement that does not include the wholesale acquisition cost (the manufacturer's list price to wholesalers or direct purchasers) for a 30-day supply of the drug. The bill requires any representative of a drug manufacturer who communicates with a health care practitioner about a drug manufactured by the drug manufacturer to disclose the wholesale acquisition cost for a 30-day supply of the drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

26 July 2018
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
26 July 2018
Introduced
Introduced in House
Source: IntroReferral
26 July 2018
Introduced
Introduced in House
Source: IntroReferral
27 July 2018
Referred
Referred to the Subcommittee on Health.
Source: Committee

Votes

No vote records are attached yet.

Versions

Introduced in House · 26 July 2018 · Download file

Documents

3 official files

Introduced in House (text)

View file Download file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Introduced in House (text)
Introduced in House · EN · 26 July 2018
View Download Open at official source
Introduced in House (PDF)
Introduced in House · EN · 26 July 2018
View Download Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 26 July 2018
Open at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Vertaal naar
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

related to → Drug-Price Transparency in Communications Act

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/115th-congress/house-bill/6576
Open data entity: https://api.congress.gov/v3/bill/115/hr/6576
us · 115-hr-6576 · source updated 5 December 2025